An interventional study of Prehabilitation Program and Non prehabilitation Program in Prehabilitation, Knee Osteoarthritis and Hip Osteoarthritis, sponsored by University of Jaén. Active, not recruiting at 1 site in Spain. Open to participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-12.
Sponsored by University of Jaén · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 100 studies in Osteoarthritis, Knee with a site in Spain — 16 open to participants now, 19 under way, 3 of them phase 3. Osteoarthritis, Knee · Spain.
Among the 100 studies in Osteoarthritis, Knee with a site in Spain, this one is the 72nd largest by planned enrollment of the 86 interventional ones that give a count, is one of 2 that started in 2025, is one of 47 with no phase, reaches primary completion later than 7 of the 18 other live ones, and was the 85th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →16 of the 100 studies in Osteoarthritis, Knee with a site in Spain are open now. Recruiting first, the newest first:
Universidad Católica San Antonio de Murcia · Sites in Spain
Ages 31+
Universidad Complutense de Madrid · Sites in Spain
Ages 45+
Novo Nordisk A/S · Sites in Spain, United States, Australia and 8 more countries
Ages 18+
Novo Nordisk A/S · Sites in Spain, United States, Australia and 7 more countries
Ages 18+
University of Valencia · Sites in Spain
Ages 50–85
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 45 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
100 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 15 · Phase 3 16 · Phase 4 8
First in 2000; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 44 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 100 across the 86 interventional studies, 153 across the 14 observational. Of the 71 that completed or were terminated, 19 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
43 of 100 have an industry lead sponsor. The 10 most frequent:
University of Jaén is the lead sponsor of 81 studies on the registry; 2 are open to participants now.
University of Jaén has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
4 of the studies in Osteoarthritis, Knee with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06721897University of JaénEffectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery. | 2026-11-30 |
| NCT07434011Universidad Complutense de MadridEfficacy of Artificial Intelligence-Assisted Therapeutic Exercise in Patients With Knee Osteoarthritis | 2027-03-15 |
| NCT07886697Universidad Rey Juan CarlosLow-Dose Radiotherapy for Painful Knee Osteoarthritis | 2027-06-30 |
| NCT07870967Universidad Católica San Antonio de MurciaUndenatured Type II Collagen for Knee Osteoarthritis Pain | 2027-07 |
Add all 4 to your calendar (.ics) → With an account.
Among the 100 studies in Osteoarthritis, Knee with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
We live in an increasingly aging society in which the incidence of osteoarticular diseases increases, among which osteoarthritis (OA) stands out. OA is a degenerative disorder of the different components of the joint leading to a progressive destruction of the same. The hip and knee being the most affected joints, OA presents multiple symptoms such as pain, stiffness and functional limitation, also causing psychological disorders such as anxiety, depression, quality of sleep and poor perception of quality of life. Conventional treatment is aimed at alleviating symptoms, but when conservative therapies fail in the more advanced stages of the disease, total joint replacement surgery or arthroplasty is the therapeutic option of choice. Strength physical exercise (PE) and aerobic training have been shown to be effective in OA, obtaining positive effects on the symptoms and on variables that deteriorate this disease. The concept of pre-habilitation or preoperative rehabilitation has been shown through other studies in different pathologies (cardiopulmonary and musculoskeletal) to have positive effects at a clinical and functional level, however, the planning of a pre-habilitation protocol in hip or knee arthroplasty is still controversial.
The purpose of this study is to determine the effect that a prehabilitation program will produce and its possible usefulness in those subjects who are waiting for a hip or knee arthroplasty. It is expected to find favorable results that support this therapy when it comes to reducing postoperative recovery times, functional capacity and other psychological variables of interest.
This powerful tool could represent a non-pharmacological and non-invasive therapy, as well as being useful and economical in the management of patients with OA in advanced stages.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The intervention group (IG) will undergo a 6-week prehabilitation program for total hip/knee replacement surgery. Once the surgery is complete, they will follow the same rehabilitation program proposed for the control group.
Other: Prehabilitation Program
The control group (CG) will carry out a post-operative physiotherapy program in addition to a home exercise program that will be shown by the physiotherapist before hospital discharge.
Other: Non prehabilitation Program
A prehabilitation programme supervised by a physiotherapist in a ward is proposed, with a frequency of 3 sessions/week on alternate days lasting 30-45 min/session, in addition to a daily physical exercise programme at home. The programme will consist of a warm-up, strength exercises with progressive loads, proprioception, balance, cardiovascular training aimed at functional work and a cool-down. The home programme will be complementary to the supervised programme, which will consist of daily sessions of 20-30 min of flexibility and proprioception exercises. The same prehabilitation protocol will be proposed for those patients awaiting total hip and knee replacement surgery.
The control group (CG) will carry out a post-operative physiotherapy program in addition to a home exercise program that will be shown by the physiotherapist before hospital discharge.
Also known as: Control Group
Measuring Quality of life
SF-12 Health Questionnaire: This is a valid instrument for measuring health-related quality of life (HRQoL). The SF-12 is a reduced version of the SF-36 questionnaire, consisting of a subset of 12 items from the SF-36, selected by multiple regression, including 1 or 2 items from each of the 8 domains of the SF-36. From the information obtained from these 12 items, the SF-12 physical and mental summary measures are obtained as the only assessments. The assessments vary between 0 (no quality of life) and 100 (maximum quality of life).
Time frame: Start of the study and week 24
Lower limb functionality
Time Up and Go Test: Evaluates functional capacity through walking and balance, as well as its probable disorders in an elderly subject. It consists of timing the time to perform the following test: get up from a chair and walk at a normal pace a distance of 3 meters, have the person turn around, walk back to the chair and sit down again (6 meters in total). This test has three levels of interpretation: normal/independent (if the subject takes less than 20 seconds), slight risk of falling (between 20-29 seconds) and high risk of falling or dependency (values greater than 30 seconds). If the patient requires technical aids, this must be indicated on the data sheet. Two attempts are made and the best time is chosen.
Time frame: Start of study, week 6, week 9 and week 24
Lower limb functionality
Sit to Stand Test: This consists of counting the number of repetitions that the person gets up and sits down in a chair for 30 seconds. To do this, the subject will be seated in the chair in a posture that allows him to place his feet flat on the floor and separated at the height of his hips, with his knees bent at just over 90º. He will be told that his arms will remain crossed in front of his chest during the test. If the subject cannot lift anything in this position, he will be allowed certain adaptations (hands on his legs or on technical aids) noting said adaptations together with the number of repetitions. Each age range and sex has variable intervals of number of repetitions, although scores below 8 indicate a high risk of falls in both sexes.
Time frame: Start of study, week 6, week 9 and week 24.
Strength
Manual dynamometer: A low-cost, noninvasive method for assessing muscle strength. It is performed using a portable pressure algometer "Pain Test FPN 100" (Wagner Instruments, USA). Three attempts are made, each separated by 30 seconds. The manual dynamometer is a valid and reliable tool for measuring muscle strength, with an ICC between moderate and high (0.55 and 0.85) depending on the muscle group evaluated.
Time frame: Start of study, week 6, week 9 and week 24 (end of intervention).
Strength
1RM - Brzycki and Wlday Formula: A test to evaluate endurance in multi-joint exercises. Its most common application is to assess changes in muscle strength during training. It is a simple and inexpensive test that does not require costly equipment. To estimate 1RM in patients with osteoarthritis, it will be calculated using the indirect Brzycki and Wlday method on the contralateral (unaffected) limb. For this, the patient must perform the maximum possible repetitions with a fixed, relatively light load (5 kg). If fewer than 10 repetitions are performed, the Brzycki formula will be applied (weight lifted / (1.0278 - (0.0278 \* number of repetitions))). If 10 or more repetitions are performed, the Wlday formula will be applied ((weight lifted \* 0.0333 \* repetitions to failure) + weight lifted)), which will give the 1RM value with the established load.
Time frame: Start of the study, week 6, week 9 and week 24 (end of the intervention)
Level of perceived exertion
Modified Borg scale: Adapted from the classic perceived exertion (RPE) scale, the modified Borg scale is used to measure dyspnea and the intensity of the entire exercise session. It has a gradation from 0 to 10, where 0 represents the absence of dyspnea/rest and 10 is the maximum degree of dyspnea/exertion, so that the subject can indicate the level of perceived exertion subjectively during the training session.
Time frame: From the start of the prehabilitation program until 6 weeks (end of the prehabilitation program)
Intensity of Pain
Numeric Pain Rating Scale- NPRS: This is a scale for assessing pain intensity in a unidimensional manner. This subjective scale consists of 11 items (0-10) where 0 corresponds to no pain and 10 to maximum pain, so that the user can communicate the level of pain he or she has or perceives while performing the task.
Time frame: Start of the intervention, week 6, week 9 and week 24.
Psychological aspects
Goldberg Anxiety and Depression Scale (GADS): It is a useful tool to guide towards the diagnosis of anxiety or depression (or both) in addition to discriminating and sizing the intensities of each of them. It is composed of 2 subscales (anxiety subscale and depression subscale) with nine questions each. In the anxiety subscale (questions 1-9) a minimum of 2 questions from the first four questions must be answered affirmatively in order to continue with the subscale. In the case of the depression subscale (questions 10-18) it is sufficient to answer affirmatively one question from questions 10-13 in order to proceed to answer the rest. The total score varies from 0-18 points so that for the anxiety subscale the cut-off points are 4 points or more and 2 or more points for the depression subscale, the maximum score being 9 points for each subscale.
Time frame: Start of intervention, week 6 and week 24.
Sleep Quality
Pittsburgh Scale: This is an instrument for assessing sleep quality. It is made up of 24 items (although only 19 are taken into account for obtaining data) divided into 7 dimensions. Each dimension has 4 values on a scale of 0 to 3. The total ICSP score is obtained from the sum of the 7 dimensions, which ranges from 0 to 21 points (the higher the score, the worse the sleep quality).
Time frame: Start of the intervention and week 24
Analgesic consumption
Analgesic consumption: An activity diary is used to mark the days of the week that drugs are taken for OA pain relief. Therefore, values are measured from 0-7 days/week
Time frame: Start and week 6.
Therapeutic adherence
Therapeutic adherence: continuous quantitative metric variable. It was collected through a registration sheet provided at the beginning of the trial. It recorded the days per week of physical activity (0-7 days/week) as well as the duration of daily physical activity, taking values of number of hours/week.
Time frame: Start of the intervention and week 6.
Treatment expectations and therapeutic satisfaction
Nottingham Health Profile: Self-administered questionnaire designed to measure health perception and assess the extent to which health problems affect daily life activities. It consists of two parts, the first consisting of 38 questions that explore 6 dimensions of health (energy, pain, physical mobility, emotional state, sleep and social isolation). The second part consists of 7 questions about the functional limitations that the health problem causes in seven situations of daily life (work, housework, social life, family life, sexual life, hobbies and free time). Each question is answered with a YES/NO. Scores range from 0 to 100 points, with 0 indicating that the subject does not suffer from any health problems and 100 indicating that he or she suffers from all of them.
Time frame: 24/48 hours post-surgery
Independent values
Age and sex
Time frame: All were measured at the start of the intervention and at week 24.
Independent Values: Weight
Weight (Kilograms)
Time frame: The start of the intervention, week 6, week 9 and at week 24.
Independent Values: Height
Height (Metre)
Time frame: The start of the intervention and at week 24.
Independent Values: body mass index (BMI)
body mass index (BMI) (kg/m2).
Time frame: The start of the intervention, week 6, week 9 and at week 24.
Independent Values: general analytical and biochemical parameters
number of white blood cells and red blood cells, number of platelets, blood hemoglobin and hematocrit value in femtoliters.
Time frame: The start of the intervention and at 24/48 hours after surgery
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Plan for Sharing IPD from a Clinical Trial: Objective: Promote transparency, reproducibility, and new knowledge generation while safeguarding participant confidentiality. Ethical and legal aspects: Verify informed consent, de-identify data, and comply with regulations (e.g., GDPR, HIPAA). Preparation: Review and anonymize data, accompanied by key documentation (data dictionary, protocol, CSR). Infrastructure: Use secure platforms (e.g., Vivli, ClinicalStudyDataRequest) with access controls and traceability. Access: Review requests based on clear criteria; require data use agreements (DUA) and ethical commitment from researchers. Timeline: Share data 6-12 months after publication, available for 5-10 years. Oversight: Monitor requests and compliance; assess impact and adjust the plan based on feedback.
Supporting information: Study protocol, Statistical analysis plan, Clinical study report
Time frame: January 2025- January 2026
Access criteria: Access Criteria for IPD Sharing: Research Purpose: Access is granted solely for valid scientific research that aligns with the objectives of the original study or advances medical knowledge. Application Requirements: Applicants must submit a detailed research proposal, including objectives, methodology, and justification for using the requested data. Researcher Qualifications: Access is limited to qualified researchers affiliated with recognized institutions. Data Use Agreement (DUA): Applicants must sign a DUA, agreeing to use the data only for the approved purpose, maintain confidentiality, and avoid re-identification of participants. Ethical Compliance: The research must have ethics committee approval and comply with relevant legal and regulatory standards. Transparency: Researchers must commit to publishing results in peer-reviewed journals or other scientific forums.
Started May 2025 (actual). Primary completion is estimated for Nov 2026, 18 months after the start.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 18 months is close to that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Jaén